policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
Vector-borne disease center established
A $250,000 gift from diagnostics company Abaxis to the Kansas State University College of Veterinary Medicine has helped establish the new Center of…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
JAVMA news
FMD vaccine first allowed to be made in U.S.
A foot-and-mouth disease vaccine conditionally approved in June is the first that can be manufactured on the U.S. mainland because it does not contain…
JAVMA news
Veterinary faculty among 2019 elected AAAS fellows
Three faculty at U.S. veterinary colleges are among 443 fellows chosen this past year by the American Association for the Advancement of Science. The…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
AVMA news
AVMA editor-in-chief becomes Equine Research Hall of Famer, with three others
AVMA Editor-In-Chief Lisa Fortier along with Drs. Katrin Hinrichs, Jennifer Anne Mumford, and Stephen M. Reed are this year’s inductees into the…
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
JAVMA news
Academic groups seek easier approval path for gene-edited food animals
Two academic groups argue that the amount of regulatory oversight for genetic changes in food animals should depend on the nature of the changes, and…